Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
Year : 2005  |  Volume : 26  |  Issue : 4  |  Page : 43-57

Hepatocellular carcinoma


Department of Medical Oncology, Tata Memorial Hospital Mumbai

Correspondence Address:
PM Parikh
Department of Medical Oncology, Tata Memorial Hospital Mumbai

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Hepatocellular carcinoma (HCC) is the fourth most common cancer worldwide. Over last two decades there is increased incidence rate and shift toward younger population. HCC is associated with conditions resulting in chronic liver injury. Malignant tumours of liver are primarily adenocarcinomas. Majority of the patients present with advanced disease. Imaging is required to assess operability. Standard treatment for operable tumour is partial hepatectomy or total hepatectomy with liver transplantation. Neoadjuvant chemotherapy; chemo-embolization or immunoembolization may make resection safer. Adjuvant chemotherapy or chemo-embolization has shown no benefit in terms of survival. Surveillance of high-risk population is a must for detection at early stages where curative therapy can be given. Patients with HCC who cannot undergo curative procedures are best treated in the setting of a clinical trial.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed781    
    Printed43    
    Emailed0    
    PDF Downloaded230    
    Comments [Add]    

Recommend this journal